Neurotoxicity of an endogenous brain amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in organotypic slice co-culture of mesencephalon and striatum

Neuroscience

Volumn 117, Issue 1, 2003, Pages 63-70

  Kotake, Y ^a,b   Ohta, S ^a   Kanazawa, I ^b   Sakurai, M ^b,c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine content; Neuronal death; Parkinson's disease; Tyrosine hydroxylase positive neuron

Indexed keywords

1 BENZYL 1,2,3,4 TETRAHYDROISOQUINOLINE; AMINE; DOPAMINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN SLICE; CELL LOSS; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITE; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FETUS; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037451791     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00789-3     Document Type: Article

References (53)

1. Abe K., Taguchi K., Wasai T., Ren J., Utsunomiya I., Shinohara T., Miyatake T., Sano T. Biochemical and pathological study of endogenous 1-benzyl-1, 2, 3, 4-tetrahydroisoquinoline-induced parkinsonism in the mouse. Brain Res. 907:2001;134-138.
2. Ara J., Przedborski S., Naini A.B., Jackson-Lewis V., Trifiletti R.R., Horwitz J., Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci USA. 95:1998;7659-7663.
3. Bella V.L., Alexianu M.E., Colom L.V., Ionescu A., Mohamed A.H., Appel S.H. Apoptosis induced by β-N-oxalylamino-L-alanine on a motoneuron hybrid cell line. Neuroscience. 70:1996;1039-1052.
4. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 3:2000;1301-1306.
5. Buchs P.A., Stoppini L., Muller D. Structural modifications associated with synaptic development in area CA1 of rat hippocampal organotypic cultures. Dev Brain Res. 71:1993;81-91.
6. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA. 80:1983;4546-4550.
7. Caparros-Lefebvre D., Elbaz A. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants a case-control study. Lancet. 354:1999;281-286.
8. + in PC12 cells insights into potential neurotoxicants in Parkinson's disease. J Neurochem. 62:1994;1503-1510.
9. Finiels-Marlier F., Marini A.M., Willians P., Paul S.M. The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from MPTP toxicity in vitro. J Neurochem. 60:1993;1968-1971.
10. Forno L.S., Langston J.W., DeLanney L.E., Irwin I., Ricaurte G.A. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol. 20:1986;449-455.
11. Gähwiler B.H. Organotypic cultures of neural tissue. Trends Neurosci. 11:1988;484-489.
12. Hao R., Norgren R.B. Jr, Lau Y., Pfeiffer R.F. Cerebrospinal fluid of Parkinson's disease patients inhibits the growth and function of dopaminergic neurons in culture. Neurology. 45:1995;138-142.
13. Hao R., Ebadi M., Pfeiffer R.F. Selegiline protects dopaminergic neurons in culture from toxic factor(s) present in the cerebrospinal fluid of patients with Parkinson's disease. Neurosci Lett. 200:1995;77-80.
14. Hayashi M., Tanii H., Horiguchi M., Hashimoto K. Cytotoxic effects of acrylamide and its related compounds assessed by protein content, LDH activity and cumulative glucose consumpution of neuron-rich cultures in a chemically defined medium. Arch Toxicol. 63:1989;308-313.
15. Katsuki H., Tomita M., Takenaka C., Shirakawa H., Shimazu S., Ibi M., Kume T., Kaneko S., Akaike A. Superoxide dismutase activity in organotypic midbrain-striatum co-cultures is associated with resistance of dopaminergic neurons to excitotoxicity. J Neurochem. 76:2001;1336-1345.
16. Kawai H., Makino Y., Hirobe M., Ohta S. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives uptake by dopamine transporter and activity to induce parkinsonism. J Neurochem. 70:1998;745-751.
17. Kawai H., Kotake Y., Ohta S. Dopamine transporter and catechol-O-methyltransferase activities are required for the toxicity of 1-(3′4′-dihydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline. Chem Res Toxicol. 13:2000;1294-1301.
18. Kohno M., Ohta S., Hirobe M. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain. Biochem Biophys Res Commun. 140:1986;448-454.
19. Kotake Y., Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem. 65:1995;2633-2638.
20. Kotake Y., Yoshida M., Ogawa M., Tasaki Y., Hirobe M., Ohta S. Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neurosci Lett. 217:1996;69-71.
21. Kotake Y., Tasaki Y., Hirobe M., Ohta S. Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice in vivo and in vitro studies. Brain Res. 787:1998;341-343.
22. Kupsch A., Loschmann P.A., Saver H., Arnold G., Renner P., Pufal D., Burg M., Wachtel H., Ten Bruggencate G., Oertel W.H. Do NMDA receptor antagonists protect against MPTP toxicity? Biochemical and immunocytochemical analyses in black mice. Brain Res. 592:1992;74-78.
23. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
25. Maeda T., Ibi M., Shimazu S., Akaike A. Co-culture with the striatum attenuates N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of rat mesencephalic slice cultures. Jpn J Pharmacol. 77:1998;161-167.
26. + analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurology. 45:1995;2240-2245.
27. Matsubara K., Gonda T., Sawada H., Uezono T., Kobayashi Y., Kawamura T., Ohtani K., Kimura K., Akaike A. Endogenously occurring β-carboline induces parkinsonism in nonprimate animals a possible protoxin in idiopathic Parkinson's disease. J Neurochem. 70:1998;727-735.
28. Matsubara K., Senda T., Uezono T., Fukushima S., Ohta S., Igarashi K., Naoi M., Yamashita Y., Ohtani K., Hayase N., Akutsu S., Kimura K. Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter. Eur J Pharmacol. 348:1998;77-84.
29. McNaught K.S., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C.D. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem Pharmacol. 56:1998;921-933.
30. Morikawa N., Nakagawa-Hattori Y., Mizuno Y. Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity. J Neurochem. 66:1996;1174-1181.
31. Morikawa N., Naoi M., Maruyama W., Ohta S., Kotake Y., Kawai H., Niwa T., Dostert P., Mizuno Y. Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes. J Neural Transm. 105:1998;677-688.
32. Nagatsu T., Yoshida M. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett. 87:1988;178-182.
33. Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci Res. 29:1997;99-111.
34. + cause nigrostriatal toxicity after substantia nigra injections in rats. Brain Res. 675:1995;279-288.
35. Ohta S., Kohno M., Makino Y., Tachikawa O., Hirobe M. Tetrahydroisoquinoline and 1-methyltetrahydroisoquinoline are present in the human brain relation to Parkinson's disease. Biomed Res. 8:1987;453-456.
36. Okada T., Shimada S., Sato K., Kotake Y., Kawai H., Ohta S., Tohyama M., Nishimura T. Tetrahydropapaveroline and its derivatives inhibit dopamine uptake through dopamine transporter expressed in HEK293 cells. Neurosci Res. 30:1998;87-90.
37. Østergaard K., Schou J.P., Zimmer J. Rat ventral mesencephalon grown as organotypic slice cultures and co-cultured with striatum, hippocampus, and cerebellum. Exp Brain Res. 82:1990;547-565.
38. Pakkenberg B., Moller A., Gundersen H.J., Mouritzen-Dam A., Pakkenberg H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry. 54:1991;30-33.
39. Reinhard J.F. Jr, Carmichael S.W., Daniels A.J. Mechanisms of toxicity and cellular resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in adrenomedullary chromaffin cell cultures. J Neurochem. 55:1990;311-320.
40. Snyder S.H., D'Amato R.J. MPTP a neurotoxin relevant to the pathophysiology of Parkinson's disease. Neurology. 36:1986;250-258.
41. Sonsalla P.K., Zeevalk G.D., Manzino L., Giovani A., Nicklas W.J. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic MPTP in mice or intranigral MPTP in rats. J Neurochem. 58:1992;398-400.
42. +) nigral toxicity in the rat by prior decortication or MK-801 treatment a stereological estimate of neuronal loss. Neurobiol Aging. 14:1993;295-301.
43. Steensen B.H., Nedergaard S., Østergaard K., Lambert J.D.C. Electrophysiological characterization of dopaminergic and non-dopaminergic neurones in organotypic slice cultures of the rat ventral mesencephalon. Exp Brain Res. 106:1995;205-214.
44. Storch A., Kaftan A., Burkhardt K., Schwarz J. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 855:2000;67-75.
45. + produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J Neurochem. 58:1992;1975-1978.
46. Strasser U., Fischer G. Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation. J Neurosci Methods. 57:1995;177-186.
47. Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J Neurochem. 57:1991;1940-1943.
48. Tipton K.F., Singer T.P. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem. 61:1993;1191-1206.
49. + neurotoxicity by N-methyl-D-aspartate antagonist. Nature. 349:1991;414-418.
50. Vornov J.J., Tasker R.C., Coyle J.T. Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neurol. 114:1991;11-22.
51. Yamamoto N., Yamada K., Kurotani T., Toyama K. Laminar specificity of extrinsic cortical connections studied in coculture preparations. Neuron. 9:1992;217-228.
52. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
53. Yoshida M., Niwa T., Nagatsu T. Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline the behavioral and biochemical changes. Neurosci Lett. 119:1990;109-111.